Literature DB >> 17202441

Establishing the use of body mass index as an indicator of nutrition risk in children with cancer.

Joshua Nething1, Karen Ringwald-Smith, Ruth Williams, Michael L Hancock, Gregory A Hale.   

Abstract

BACKGROUND: The negative health consequences of malnutrition in the pediatric oncology patient are well known. The purpose of this study was to determine the usefulness of body mass index (BMI) for age as a tool to prospectively identify pediatric cancer patients at risk for malnutrition and to determine the BMI percentile that would be required to identify at-risk patients.
METHODS: This study was conducted by a retrospective chart review of 1839 newly diagnosed acute lymphoblastic leukemia patients at St. Jude Children's Research Hospital. Those falling below the 10(th) percentile on any one category of height for age (HFA), weight for age (WFA), or weight for height (WFH) were classified with regard to nutrition risk and compared with those identified as at risk by BMI for age (BFA). The BMI percentiles of the lower 9(th)-11(th) percentile patients on the HFA, WFA, and WFH growth charts were averaged in an attempt to determine a useful value to identify nutrition risk.
RESULTS: Lack of agreement was found to exist between BFA and HFA in identifying patients at risk for malnutrition, and also between BFA and WFA. Significant agreement was found to exist between BFA and WFH. The BMI percentile required to identify those at risk for malnutrition by the other growth charts would classify too many patients as being at risk for malnutrition to be considered clinically useful.
CONCLUSIONS: Although research has shown BMI is appropriate to use in the nutrition assessment of children, its usefulness has not been confirmed in the pediatric oncology patient; therefore, further study is warranted. BFA assessment should be included in the nutrition survey of new pediatric oncology patients, along with other parameters, but it cannot be recommended as the sole indicator of nutrition status at this time.

Entities:  

Mesh:

Year:  2007        PMID: 17202441     DOI: 10.1177/014860710703100153

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  2 in total

1.  Does body mass index at diagnosis or weight change during therapy predict toxicity or survival in intermediate risk rhabdomyosarcoma? A report from the Children's Oncology Group Soft Tissue Sarcoma Committee.

Authors:  Megan E Burke; Elizabeth R Lyden; Jane L Meza; Elena J Ladas; Roshni Dasgupta; Ellen A Wiegner; Carola A S Arndt
Journal:  Pediatr Blood Cancer       Date:  2013-01-17       Impact factor: 3.167

2.  Classification of malnutrition in cystic fibrosis: implications for evaluating and benchmarking clinical practice performance.

Authors:  HuiChuan J Lai; Suzanne M Shoff
Journal:  Am J Clin Nutr       Date:  2008-07       Impact factor: 7.045

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.